Please login to the form below
type 2 diabetes
This page shows the latest type 2 diabetes news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
The condition is more common in those living with obesity – 82% of people with NASH live with obesity – and conditions related to obesity, including type 2 diabetes – 44% of people with ... NASH live with type 2 diabetes.
Latest news
-
Eli Lilly announces $2.1bn investment in new manufacturing sites
of type 2 diabetes.
-
NICE recommends AZ’s Forxiga for kidney disease
NICE’s most recent decision follows its draft recommendation – issued in November 2021 – which removed the urine albumin-to-creatinine ratio (uACR) testing restriction in the type 2 diabetes population, allowing ... of care in adult patients with
-
Eli Lilly focuses on 2022 launches as revenues climb by 18%
Diabetes medicine Trulicity (dulaglutide), immunology blockbuster Taltz (ixekizumab), breast cancer therapy Verzenio (abemaciclib) and migraine prevention antibody Emgality (galcanezumab-gnlm) each saw revenues rise by more than 30% year on year.
-
$47.5m research centre to seek genetic insights into disease
be on understanding type 2 diabetes and obesity and mapping human gene regulation.
-
AstraZeneca’s Forxiga approved in Japan for the treatment of CKD
chronic kidney disease patients with and without type 2 diabetes.”. ... Forxiga was approved as ‘Farxiga’ for the treatment of CKD in adults with and without type 2 diabetes in the US in April, after demonstrating results from a phase 3 study
More from news
Approximately 36 fully matching, plus 469 partially matching documents found.
Latest Intelligence
-
Mapping patient pathways with a focus on patient-centricity: the role of medical education
You only need look at the National Institute for Health and Care Excellence (NICE) pathways in adult Type 2 Diabetes (T2D) to see how many specialists are involved, including the diabetologist, ... Currently, we are developing MDT education in oncology,
-
Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
From adherence to a healthy lifestyle reducing mortality from type 2 diabetes and cardiovascular disease, to using psychological interventions in managing chronic symptoms, such as pain and fatigue. ... engaging. 2. Upskill.Supporting HCPs to identify
-
Patient diversity in clinical trials needs to be centre stage
UK diabetes trials which showed a 5.5% South Asian participation rate despite that group representing 11.2% of the UK type 2 diabetes population.
-
Understand, identify and partner with HCPs to improve patient support
Diabetes consultant, Partha Kar’s Twitter account was mentioned over 250 times by his HCP peers. ... In one post Paul Mason, a registrar in sports and exercise medicine, shared with his network that 1 in 5 type 2 diabetes patients also have autoimmune
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
1) receptor agonists for type 2 diabetes.
More from intelligence
Approximately 5 fully matching, plus 48 partially matching documents found.
Latest appointments
-
Roche’s Torsten Hoffmann to join Zealand Pharma
In his new role at Zealand, Dr Hoffmann joins a more compact company focused on the discovery of drugs in cardio-metabolic diseases, diabetes and obesity. ... Its lead product is the GLP-1 agonist lixisenatide, which is licensed to Sanofi who markets it
-
bmore creative hires Kush Rach as new business director
He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2 ... diabetes. Ben Blackmore, bmore creative's MD, told The Directory: "We are
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Onyx Health Tackles Type 2 Diabetes with Diabetes Lifestyle Doctors
The medical duo are NHS doctors and have frontline hospital and primary care experience, supporting type 2 diabetes patients with their healthcare needs. ... Through our ongoing work with the NHS, we continue to treat countless people with type 2
-
#DemandDiversity: The science behind diversity
Caucasian and Asian women are more likely to develop osteoporosis than women of other ethnic backgrounds, andare more likely to develop Type 2 diabetes than the rest of the population. ... 44 (0) 330 995 0656. Address:. Suite 2.10, Jactin House. 24 Hood
-
Welcoming the latest member of the Porterhouse Medical Advisory Group
Jess recently joined Porterhouse as an Associate Medical Writer. She has a medical degree from the University of Liverpool and worked in a variety of specialties, including paediatric rheumatology, diabetes and ... Additionally, she also volunteered on a
-
Diversity in clinical trials needs to extend beyond COVID-19 vaccine trials
Developing type 2 diabetes is reported to be as much as 6 times higher in South Asians than in Europeans. ... We’ve got the need-to-know information in our white paper, . 44 (0) 330 995 0656. Address:. Suite 2.10, Jactin House. 24 Hood Street.
-
Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
The PM Society Digital Awards 2020 saw Envision pick up two Silver awards for Congress, Meetings &Events and for Innovation – Creativity as a result of its “See through diabetes” work in ... positively impact the lives of Type 2 Diabetes (T2D)
More from PMHub
Approximately 1 fully matching, plus 25 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
foxandcat.online
We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
